State treasurer balks at State Health Plan coverage of weight loss drugs - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
October 25, 2023 Newswires
Share
Share
Post
Email

State treasurer balks at State Health Plan coverage of weight loss drugs

Mooresville Tribune (NC)

The increasingly high cost of certain popular weight-loss drugs, such as Wegovy and Saxenda, has prompted state Treasurer Dale Folwell to urge the State Health Plan to end insurance coverage.

The SHP is North Carolina's largest purchaser of medical and pharmaceutical services and is self-funded.

It covers nearly 740,000 teachers, state employees, legislators, retirees and their dependents. The state treasurer's office oversees the plan.

Folwell said in a statement Tuesday his recommendation to the SHP board of trustees is based on how global pharmaceutical manufacturer Novo Nordisk is pricing its weight-loss drugs in the U.S. compared with other countries.

The weight-loss medications are being currently used by more than 23,000 SHP members with a net cost of more than $800 per member per month.

"It defies logic that Novo Nordisk can sell the exact same product in the Netherlands for $296 per month and in the United States for more than $800 per month," Folwell said.

"They should be investigated by the Federal Trade Commission for unfair and deceptive business practices."

Wegovy, which contains the active ingredient semaglutide, is specifically approved for chronic weight management.

Semaglutide imitates a hormone called glucagon-like peptide-1 (GLP-1), which prompts the body to produce more insulin and makes a person feel satiated, according to an Oct. 16 article in Scientific American.

The ingredient has been shown to help people lose an average of about 15% of their weight.

According to the treasurer's office, the SHP spent $52.3 million on these two medications during the first half of 2022, accounting for 2.6% of the manufacturer's entire North American profits on these products.

SHP spending on the two medications is projected to exceed $170 million in 2024, jumping to more than $1 billion over the next six years.

Folwell's recommendation comes as the SHP faces a $4.2 billion budget gap over the next five years.

The Republican sponsored 2023-24 state budget provides $240 million less to the SHP than was requested over the next two years.

Under Folwell's direction, the SHP has attempted to remain financially solvent by capping or reducing its costs as much as possible, and by implementing strategic initiatives that seek to maintain or lower dependent premiums to attract younger members and families.

Novo Nordisk recently reported a 32% increase in global operating profit for the first half of fiscal 2023.

Novo Nordisk said Wegovy sales in North America increased by 344% during that period, while Saxenda increased by 27%. Total North American sales for both products were reported as $2.02 billion.

SHP staff estimates that continuing to cover this class of drugs for weight loss will result in a premium increase of $48.50 per subscriber per month — doubling the premium for individual subscribers.

"We are not questioning the efficacy of the drugs, but we simply can't afford these medications at the manufacturer's current price point," Folwell said.

"It's price gouging. We just want to pay the same price that Novo Nordisk charges its customers in their home region."

According to the Scientific American article, most private insurance companies and federal health programs don't cover weight-loss drugs, and Ozempic, Wegovy and Mounjaro each cost $1,000 or more per month out of pocket.

Medicare has been explicitly forbidden by law from providing coverage for weight-loss treatments since 2003.

The ban was implemented in part because of concerns over the safety of weight-loss drugs at the time, such as the combination of fenfluramine and phentermine, or fen-phen, which was associated with life-threatening hypertension and heart valve issues.

There are other potential side effects with semaglutide medications that include nausea, fatigue, lightheadedness, decreased muscle mass and chronic paralysis of the digestive system.

Older

National Conference Brings Together Fraud Fighting Attorneys

Newer

Malek: Medicare dis-Advantage

Advisor News

  • The Gen Z money paradox
  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
More Advisor News

Annuity News

  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • Boomers want retirement protection, but their actions don’t match their mindset
  • NAIC task force to address LTC riders
  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
  • Jackson Launches Direct-to-Consumer Annuity Offering
More Annuity News

Health/Employee Benefits News

  • Samantha Wildow: Mercy Health warns thousands of Medical Mutual of Ohio patients may go out-of-network in 2027
  • Reports Outline Managed Care Study Results from Harvard University (Inpatient-Only List Removals Shifted Procedures To The Outpatient Setting And Reduced Medicare Spending): Managed Care
  • Health and Humor: Picking a Medicare insurance plan is daunting
  • Obamacare is getting more expensive in Indiana
  • Hays City Commission to consider bids for health insurance, sports complex improvements
More Health/Employee Benefits News

Life Insurance News

  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • U-Haul Holding Company to Participate in Deutsche Bank Conference
  • NAIC task force to address LTC riders
  • Protective names Kurt Meyers Chief Legal Officer and Fernando Levy Chief Digital & AI Officer
  • Best’s Commentary: Shanghai Cross-Border Investment Pilot Unlocks Overseas Growth Potential of China Non-Life Companies
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.